PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 52 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $6,000 | -70.0% | 5,874 | -60.7% | 0.00% | – |
Q2 2020 | $20,000 | +300.0% | 14,951 | +272.3% | 0.00% | – |
Q1 2020 | $5,000 | +66.7% | 4,016 | +167.7% | 0.00% | – |
Q4 2019 | $3,000 | -40.0% | 1,500 | -60.6% | 0.00% | – |
Q1 2019 | $5,000 | -76.2% | 3,806 | -42.2% | 0.00% | – |
Q4 2018 | $21,000 | -25.0% | 6,585 | -44.7% | 0.00% | – |
Q3 2018 | $28,000 | -6.7% | 11,904 | +10.9% | 0.00% | – |
Q2 2018 | $30,000 | +150.0% | 10,731 | +328.6% | 0.00% | – |
Q1 2018 | $12,000 | +1100.0% | 2,504 | +2811.6% | 0.00% | – |
Q4 2017 | $1,000 | – | 86 | +21.1% | 0.00% | – |
Q3 2017 | $0 | – | 71 | -17.4% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 86 | -54.5% | 0.00% | – |
Q1 2017 | $1,000 | -93.3% | 189 | -84.9% | 0.00% | – |
Q4 2016 | $15,000 | -59.5% | 1,255 | -47.6% | 0.00% | – |
Q3 2016 | $37,000 | +54.2% | 2,396 | +22.8% | 0.00% | – |
Q2 2016 | $24,000 | +700.0% | 1,951 | +443.5% | 0.00% | – |
Q1 2016 | $3,000 | – | 359 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|